Sucralfate is NOT indicated for acute gastroenteritis
Sucralfate has no role in the treatment of acute gastroenteritis in adults. The drug is FDA-approved exclusively for duodenal ulcer treatment and maintenance therapy, not for infectious diarrhea or gastroenteritis 1.
Why Sucralfate is Not Appropriate
The 2017 IDSA guidelines for infectious diarrhea management make no mention of sucralfate among recommended therapies 2. The evidence-based treatment algorithm for acute gastroenteritis focuses on:
Primary Treatment (Strong Evidence)
- Oral rehydration solution (ORS) for mild-to-moderate dehydration 2
- Early resumption of normal diet once rehydrated 2
- Continued breast-feeding in infants 2
Ancillary Therapies (After Adequate Hydration)
- Loperamide may be given to immunocompetent adults with watery diarrhea (avoid in bloody diarrhea or fever) 2
- Ondansetron for vomiting to facilitate oral rehydration in children >4 years 2
- Probiotics (specific strains like Lactobacillus GG or Saccharomyces boulardii) may reduce symptom duration 2
What Sucralfate Actually Does
Sucralfate works by forming a protective barrier over ulcerated gastric/duodenal mucosa 1, 3. This mechanism is irrelevant to gastroenteritis, which involves:
- Intestinal inflammation from viral/bacterial pathogens
- Secretory diarrhea
- Fluid and electrolyte losses
The drug's FDA-approved dosing (1g four times daily for duodenal ulcer) 1 addresses peptic ulcer disease pathophysiology, not infectious enteritis.
Critical Pitfall to Avoid
Do not confuse gastroenteritis with peptic ulcer disease or NSAID-induced gastropathy (where sucralfate has demonstrated efficacy 4). Gastroenteritis presents with acute diarrhea ± vomiting, while peptic ulcer disease presents with epigastric pain and potential GI bleeding.
The evidence-based approach to mild-to-moderate gastroenteritis is straightforward: rehydrate with ORS, maintain nutrition, and consider antimotility/antiemetic agents only after adequate hydration is achieved 2. Antimicrobials are reserved for specific pathogens (e.g., C. difficile, severe bacterial infections, parasites) 2.